C-reactive Protein

Cocoa Flavanol Trial Links Daily Extract to Lower Inflammation in Older Adults

New biomarker data from the COSMOS trial show a sustained hsCRP decline, strengthening a potential mechanism for the trial’s earlier mortality signal.